Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac R Rodriguez-Chavez

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Avian Pathology : Journal of the W.V.P.A|November 13, 2002
Characterization of the antigenic, immunogenic, and pathogenic variation of infectious bursal disease virus due to propagation in different host systems (bursa, embryo, and cell culture). II. Antigenicity at the epitope levelIsaac R Rodriguez-Chavez, John K Rosenberger, Sandra S Cloud
Avian Pathology : Journal of the W.V.P.A|November 13, 2002
Characterization of the antigenic, immunogenic, and pathogenic variation of infectious bursal disease virus due to propagation in different host systems (bursa, embryo, and cell culture). I. Antigenicity and immunogenicityIsaac R Rodriguez-Chavez, John K Rosenberger, Sandra S Cloud
JMIR AI|June 12, 2025
AI-Powered Drug Classification and Indication Mapping for Pharmacoepidemiologic Studies: Prompt Development and ValidationBenjamin Ogorek, Thomas Rhoads, Eric Finkelman, et al.
Avian Pathology : Journal of the W.V.P.A|November 13, 2002
Characterization of the antigenic, immunogenic, and pathogenic variation of infectious bursal disease virus due to propagation in different host systems (bursa, embryo, and cell culture). III. PathogenicityIsaac R Rodriguez-Chavez, John K Rosenberger, Sandra S Cloud, et al.
Digital Health|January 5, 2023
Verification, analytical validation and clinical validation (V3) of wearable dosimeters and light loggersManuel Spitschan, Karin Smolders, Benjamin Vandendriessche, et al.
Digital Biomarkers|December 5, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical TrialsBohdana Ratitch, Isaac R Rodriguez-Chavez, Abhishek Dabral, et al.
Current HIV/AIDS Reports|March 9, 2006
Current advances and challenges in HIV-1 vaccinesIsaac R Rodriguez-Chavez, Mary Allen, Edgar L Hill, et al.
Blood|March 2, 2006
Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcomaRichard F Little, James M Pluda, Kathleen M Wyvill, et al.
Critical Reviews in Immunology|January 17, 2008
Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activityRobert Yarchoan, James M Pluda, Kathleen M Wyvill, et al.
The Journal of Infectious Diseases|July 9, 2010
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccinePeter Gilbert, Maggie Wang, Terri Wrin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Avian Pathology : Journal of the W.V.P.A|November 13, 2002
Characterization of the antigenic, immunogenic, and pathogenic variation of infectious bursal disease virus due to propagation in different host systems (bursa, embryo, and cell culture). II. Antigenicity at the epitope levelIsaac R Rodriguez-Chavez, John K Rosenberger, Sandra S Cloud
Avian Pathology : Journal of the W.V.P.A|November 13, 2002
Characterization of the antigenic, immunogenic, and pathogenic variation of infectious bursal disease virus due to propagation in different host systems (bursa, embryo, and cell culture). I. Antigenicity and immunogenicityIsaac R Rodriguez-Chavez, John K Rosenberger, Sandra S Cloud
JMIR AI|June 12, 2025
AI-Powered Drug Classification and Indication Mapping for Pharmacoepidemiologic Studies: Prompt Development and ValidationBenjamin Ogorek, Thomas Rhoads, Eric Finkelman, et al.
Avian Pathology : Journal of the W.V.P.A|November 13, 2002
Characterization of the antigenic, immunogenic, and pathogenic variation of infectious bursal disease virus due to propagation in different host systems (bursa, embryo, and cell culture). III. PathogenicityIsaac R Rodriguez-Chavez, John K Rosenberger, Sandra S Cloud, et al.
Digital Health|January 5, 2023
Verification, analytical validation and clinical validation (V3) of wearable dosimeters and light loggersManuel Spitschan, Karin Smolders, Benjamin Vandendriessche, et al.
Digital Biomarkers|December 5, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical TrialsBohdana Ratitch, Isaac R Rodriguez-Chavez, Abhishek Dabral, et al.
Current HIV/AIDS Reports|March 9, 2006
Current advances and challenges in HIV-1 vaccinesIsaac R Rodriguez-Chavez, Mary Allen, Edgar L Hill, et al.
Blood|March 2, 2006
Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcomaRichard F Little, James M Pluda, Kathleen M Wyvill, et al.
Critical Reviews in Immunology|January 17, 2008
Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activityRobert Yarchoan, James M Pluda, Kathleen M Wyvill, et al.
The Journal of Infectious Diseases|July 9, 2010
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccinePeter Gilbert, Maggie Wang, Terri Wrin, et al.
Pageof 2